Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 4/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | SAT1 | P21673 | 1/20 | 0.34 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL924604 | 0.87 | — | — | |
| Methyl Phosphonate SCHEMBL16143409 | 0.79 | — | — | |
| Phosphoric Acid SCHEMBL10935355 | 0.75 | FDPS (0.47) | CA2FDPSLPAR3LPAR2LPAR1 | |
| Phosphoric Acid SCHEMBL337762 | 0.75 | — | — | |
| Phosphoric Acid SCHEMBL17748944 | 0.75 | FDPS (0.47) | CA2FDPSLPAR3LPAR2LPAR1 | |
| Phosphoric Acid SCHEMBL15540528 | 0.75 | FDPS (0.47) | CA2FDPSLPAR3LPAR2LPAR1 | |
| Phosphoric Acid SCHEMBL6827845 | 0.75 | FDPS (0.47) | CA2FDPSLPAR3LPAR2LPAR1 | |
| Phosphoric Acid SCHEMBL9588189 | 0.75 | FDPS (0.47) | CA2FDPSLPAR3LPAR2LPAR1 | |
| Phosphoric Acid SCHEMBL21081718 | 0.75 | FDPS (0.47) | CA2FDPSLPAR3LPAR2LPAR1 | |
| Phosphoric Acid SCHEMBL8863040 | 0.72 | FDPS (0.45) | CA2FDPSLPAR3LPAR2LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7576201-B2 | Electrochromic compound | NTERA LIMITED (IE) | 2009-08-18 | — | — | US | disclosed |
| US-20080167465-A1 | Electrochromic compound | FITZMAURICE DONALD | 2008-07-10 | — | — | US | disclosed |
| US-7358358-B2 | Electrochromic compound | NTERA LIMITED (IE) | 2008-04-15 | — | — | US | disclosed |
| US-7253940-B2 | Nanoporous and nanocrystalline film and electrochromic device | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND (IE) | 2007-08-07 | — | — | US | disclosed |
| US-20050128562-A1 | Nanoporous and nanocrystalline film and electrochromic device | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND | 2005-06-16 | — | — | US | disclosed |
| US-20050128561-A1 | Electrochromic compound | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND | 2005-06-16 | — | — | US | disclosed |
| US-6870657-B1 | Electrochromic device | UNIVERSITY COLLEGE DUBLIN (IE) | 2005-03-22 | — | — | US | disclosed |
| EP-1500969-A1 | Compound and its use in electrochromic devices | UNIVERSITY COLLEGE DUBLIN (IE) | 2005-01-26 | — | — | EP | disclosed |
| EP-1224505-B1 | ELECTROCHROMIC DEVICE | UNIV DUBLIN (IE) | 2005-01-12 | — | — | EP | disclosed |
| EP-1224505-A1 | ELECTROCHROMIC DEVICE | UNIVERSITY COLLEGE DUBLIN (IE) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001027690-A2 | ELECTROCHROMIC DEVICE | UNIVERSITY COLLEGE DUBLIN (IE) | 2001-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167465-A1 | Electrochromic compound | KCNH2, PRDM9, H1-10 | CA2 2638/4885FDPS 1990/4885LPAR3 3496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.